| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| RUNX1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-Mock-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0002.2
|
| RUNX1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-PU.1-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0002.2
|
| RUNX1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-PU.1-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0002.2
|
| RUNX1 |
Dombi23 (primary keratinocytes) |
day 0 of differentiation |
Permissive
|
Homo sapiens |
GSE98483
...
|
MA0002.2
|
| RUNX1 |
ILC2 (type 2 Innate lympoid cells) |
Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung |
Permissive
Robust
|
Mus musculus |
GSE111871
...
|
MA0002.2
|
| RUNX1 |
TF-1 (erythroleukemia) |
Genotype: wildtype; Treatment: DOX for 6 days; |
Permissive
|
Homo sapiens |
GSE73207
...
|
MA0002.2
|
| RUNX1 |
TF-1 (erythroleukemia) |
Genotype: wildtype; Treatment: DOX for 6 days; |
Permissive
|
Homo sapiens |
GSE73207
...
|
MA0002.2
|
| RUNX1 |
TF-1 (erythroleukemia) |
Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days; |
Permissive
Robust
|
Homo sapiens |
GSE73207
...
|
MA0002.2
|
| RUNX1 |
myeloid cell |
Sex: male; Tissue: Venous blood; Age: 45-50; Genotype: RUNX1 mutant; |
Permissive
|
Homo sapiens |
GSE111821
...
|
MA0002.2
|
| RUNX1 |
myeloid cell |
Sex: male; Tissue: Venous blood; Age: 45-50; Genotype: RUNX1 mutant; |
Permissive
|
Homo sapiens |
GSE111821
...
|
MA0002.2
|
Showing 10 records in page 742
from 963 pages